Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Infectious diseases programme takes on the big three

This article was originally published in Clinica

Executive Summary

Advances in the diagnosis of malaria and tuberculosis are some of the ambitious aims of the National Institute of Allergy and Infectious Diseases' (NIAID) global disease control initiative. The plan targets HIV/AIDS, along with malaria and TB, these three diseases being the leading infectious killers. The Institute's research plan, unveiled last week, provides short-, mid- and long-term objectives for combating this group of diseases, which were singled out by the Group of Eight nations in July 2000.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT071149

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel